EDLundereng
@edlundereng.bsky.social
Oncology nurse and PhD-student at Oslo university hospital and University of Oslo.
Humbled and grateful to be part of the EU-funded MyPath project, and to see our research on patient-centered cancer care recognized on #WorldCancerResearchDay. Looking forward to continuing working towards more patient-centered cancer care in Europe!
September 24, 2025 at 2:44 PM
Humbled and grateful to be part of the EU-funded MyPath project, and to see our research on patient-centered cancer care recognized on #WorldCancerResearchDay. Looking forward to continuing working towards more patient-centered cancer care in Europe!
Reposted by EDLundereng
New in JMIR: Improving the Implementation of ##Patient-Reported Outcome Measure in Clinical Practice: Tackling Current Challenges With Innovative #Digital Communication Technologies
Improving the Implementation of ##Patient-Reported Outcome Measure in Clinical Practice: Tackling Current Challenges With Innovative #Digital Communication Technologies
Implementation of ##Patient-reported outcome measures (PROMs) in clinical practice is challenging. We believe effective communication is key to realizing the clinical benefits of PROMs. Communication processes for PROMs in clinical practice typically…
dlvr.it
February 5, 2025 at 7:30 PM
Exciting Phase II results on high-dose vitamin C in PDAC! 🧪📈 tinyurl.com/msswxk6p
☣️ Potential survival benefits & better chemo tolerance
⛔️ Methodological limitations exist warranting some caution
✅️ A Phase III trial is crucial to confirm effectiveness.
Hope to see it move forward!
#WorldCancerDay
☣️ Potential survival benefits & better chemo tolerance
⛔️ Methodological limitations exist warranting some caution
✅️ A Phase III trial is crucial to confirm effectiveness.
Hope to see it move forward!
#WorldCancerDay
A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer
Patients with metastatic pancreatic ductal adenocarcinoma (PDAC) have poor 5-year survival. Pharmacological ascorbate (P-AscH-, high dose, intravenous…
www.sciencedirect.com
February 4, 2025 at 9:48 PM
Exciting Phase II results on high-dose vitamin C in PDAC! 🧪📈 tinyurl.com/msswxk6p
☣️ Potential survival benefits & better chemo tolerance
⛔️ Methodological limitations exist warranting some caution
✅️ A Phase III trial is crucial to confirm effectiveness.
Hope to see it move forward!
#WorldCancerDay
☣️ Potential survival benefits & better chemo tolerance
⛔️ Methodological limitations exist warranting some caution
✅️ A Phase III trial is crucial to confirm effectiveness.
Hope to see it move forward!
#WorldCancerDay
Great reminder that tackling cancer isn’t just about prevention and treatment - it’s also about how we care for patients. I'm proud to be part of the EU-funded #MyPathEU, developing a digital solution to make patient-centered cancer care more integrated and accessible across Europe. #WorldCancerDay
February 4, 2025 at 9:34 PM
Great reminder that tackling cancer isn’t just about prevention and treatment - it’s also about how we care for patients. I'm proud to be part of the EU-funded #MyPathEU, developing a digital solution to make patient-centered cancer care more integrated and accessible across Europe. #WorldCancerDay